Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.29% |
| 2 | Financials | 4.55% |
| 3 | Industrials | 4.18% |
| 4 | Healthcare | 4.08% |
| 5 | Consumer Discretionary | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8101
Immersion
IMMR
$249M
| $174K | ﹤0.01% |
23,453
-28,010
| -54% | -$210K |
|
|
QTNT
8102
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $174K | ﹤0.01% |
458
+153
| +50% | +$50.7K |
|
8103
CALL
BioLife Solutions
BLFS
$1.72B
| $173K | ﹤0.01% |
+10,700
| New | +$174K |
|
|
IMGN
8104
PUT
DELISTED
Immunogen Inc
IMGN
| $173K | ﹤0.01% |
33,900
+12,000
| +55% | +$40.7K |
|
8105
CALL
American Superconductor
AMSC
$1.55B
| $172K | ﹤0.01% |
21,900
-12,000
| -35% | -$96.7K |
|
8106
CALL
Voyager Therapeutics
VYGR
$201M
| $172K | ﹤0.01% |
12,300
-3,500
| -22% | -$50.9K |
|
|
SPNE
8107
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $172K | ﹤0.01% |
+14,305
| New | +$175K |
|
8108
Aldeyra Therapeutics
ALDX
$94.1M
| $171K | ﹤0.01% |
29,363
+12,148
| +71% | +$70.2K |
|
|
ENZ
8109
DELISTED
Enzo Biochem, Inc.
ENZ
| $171K | ﹤0.01% |
64,993
-53,523
| -45% | -$160K |
|
8110
Grupo Aval
AVAL
$6.29B
| $170K | ﹤0.01% |
+19,519
| New | +$157K |
|
8111
CALL
1-800-Flowers.com
FLWS
$262M
| $170K | ﹤0.01% |
11,700
-600
| -5% | -$8.15K |
|
8112
CALL
Talphera
TLPH
$63.8M
| $170K | ﹤0.01% |
4,035
+1,560
| +63% | +$63.7K |
|
|
BCLI
8113
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $169K | ﹤0.01% |
+2,633
| New | +$153K |
|
8114
PUT
Kosmos Energy
KOS
$1.51B
| $169K | ﹤0.01% |
+29,600
| New | +$179K |
|
|
RWT
8115
PUT
Redwood Trust
RWT
$604M
| $169K | ﹤0.01% |
+10,200
| New | +$168K |
|
8116
ADMA Biologics
ADMA
$2.12B
| $168K | ﹤0.01% |
41,907
-6,904
| -14% | -$30.1K |
|
8117
Seres Therapeutics
MCRB
$45.6M
| $168K | ﹤0.01% |
2,437
+1,542
| +172% | +$114K |
|
|
YRD
8118
Yiren Digital
YRD
$104M
| $168K | ﹤0.01% |
30,286
-3,459
| -10% | -$20.3K |
|
8119
PUT
Ardelyx
ARDX
$1.05B
| $167K | ﹤0.01% |
22,200
+2,400
| +12% | +$14.6K |
|
|
CLSD
8120
DELISTED
Clearside Biomedical
CLSD
| $167K | ﹤0.01% |
+3,839
| New | +$80.7K |
|
8121
CALL
Harrow
HROW
$1.5B
| $167K | ﹤0.01% |
21,500
+1,900
| +10% | +$11K |
|
|
8122
PUT
Harrow
HROW
$1.5B
| $167K | ﹤0.01% |
21,500
+700
| +3% | +$4.05K |
|
8123
PUT
abrdn Physical Gold Shares ETF
SGOL
$7.47B
| $167K | ﹤0.01% |
11,400
-56,600
| -83% | -$809K |
|
|
AGS
8124
PUT
DELISTED
PlayAGS
AGS
| $166K | ﹤0.01% |
13,700
+800
| +6% | +$9.13K |
|
8125
NCS Multistage Holdings
NCSM
$136M
| $166K | ﹤0.01% |
3,958
-1,547
| -28% | -$67.6K |
|
Similar funds
Ken Griffin's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.
Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.
- Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
- Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Ken Griffin opened 1,220 new positions and closed 1,266 in Q4 2019.
- Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.